These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9133464

  • 21. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I.
    J Immunol; 2000 May 15; 164(10):5258-68. PubMed ID: 10799887
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
    Murphy B, Kim KS, Buelow R, Sayegh MH, Hancock WW.
    Transplantation; 1997 Jul 15; 64(1):14-9. PubMed ID: 9233694
    [Abstract] [Full Text] [Related]

  • 28. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
    Yang Z, Rostami S, Koeberlein B, Barker CF, Naji A.
    Transplantation; 1999 Jun 27; 67(12):1517-23. PubMed ID: 10401757
    [Abstract] [Full Text] [Related]

  • 29. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
    Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH.
    J Immunol; 2003 Mar 15; 170(6):2949-55. PubMed ID: 12626546
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B, Gupta S, Chuzhin Y, Kalergis AM, Budhai L, Zhang M, Droguett G, Horwitz MS, Chowdhury JR, Nathenson SG, Davidson A.
    Transplantation; 2001 Mar 27; 71(6):801-11. PubMed ID: 11330546
    [Abstract] [Full Text] [Related]

  • 32. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A, Tu Y, Arima T, Linsley PS, Flye MW.
    Surgery; 1996 Aug 27; 120(2):205-12. PubMed ID: 8751584
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection.
    Dong VM, Yuan X, Coito AJ, Waaga AM, Sayegh MH, Chandraker A.
    Transplantation; 2002 Apr 27; 73(8):1310-7. PubMed ID: 11981427
    [Abstract] [Full Text] [Related]

  • 34. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.
    Guillot C, Ménoret S, Guillonneau C, Braudeau C, Castro MG, Lowenstein P, Anegon I.
    Blood; 2003 Apr 15; 101(8):3325-33. PubMed ID: 12515725
    [Abstract] [Full Text] [Related]

  • 35. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
    Newell KA, He G, Guo Z, Kim O, Szot GL, Rulifson I, Zhou P, Hart J, Thistlethwaite JR, Bluestone JA.
    J Immunol; 1999 Sep 01; 163(5):2358-62. PubMed ID: 10452966
    [Abstract] [Full Text] [Related]

  • 36. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S.
    Transplantation; 2001 Oct 27; 72(8):1423-32. PubMed ID: 11685115
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 39. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 40. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged survival of heart allograft.
    Hayashi S, Guang-Lin M, Yokoyama I, Namii Y, Hamada H, Nakao A.
    Transpl Int; 2000 Oct 15; 13 Suppl 1():S329-32. PubMed ID: 11112025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.